Log in | Register
Search PharmPro
Advanced Search
Tuesday, October 4, 2011
Chris Viehbacher, PhRMA's chairman and the CEO of Sanofi shares his thoughts about the value of new medicines, Medicare Part D, what inspires him each day, and what is "not only our mission, but our responsibility."
Click to jump to comments
4 hours ago
5 hours ago
More Latest Headlines >>
Apr 23 | The QA Pharm
It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).
Apr 16 | Girish Malhotra, PE, President, EPCOT International
The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.
More Blogs >>
May 17 | Video
A new study found Xalkori effective in treating anaplastic lymphoma among children, an encouraging development for gene-targeted therapy.
May 14 | Video
Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.
May 3 | Video
A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.
Apr 29 | Video
With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.
More Multimedia >>